id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0599-0043,FDA,FDA-2011-N-0599,"Allergy Laboratories, Inc., Opportunity for Hearing on Proposal To Revoke
U.S.; License No. 103",Notice,General Notice,2014-04-30T04:00:00Z,2014,4,2014-04-30T04:00:00Z,2014-07-01T03:59:59Z,2014-04-30T13:49:32Z,2014-09771,0,0,09000064816d6c26
FDA-2011-N-0599-0040,FDA,FDA-2011-N-0599,"Letter from Allergy Laboratories, Inc to FDA CBER",Other,Letter(s),2014-04-28T04:00:00Z,2014,4,2014-04-28T04:00:00Z,,2014-04-28T17:06:56Z,,0,0,09000064816d1f3a
FDA-2011-N-0599-0042,FDA,FDA-2011-N-0599,"Letter from  FDA/CBER to Allergy Laboratories, Inc",Other,Letter(s),2014-04-28T04:00:00Z,2014,4,2014-04-28T04:00:00Z,,2014-04-28T17:16:16Z,,0,0,09000064816d21b3
FDA-2011-N-0599-0041,FDA,FDA-2011-N-0599,"Letter from Allergy Laboratories, Inc to FDA CBER",Other,Letter(s),2014-04-28T04:00:00Z,2014,4,2014-04-28T04:00:00Z,,2014-04-28T17:11:46Z,,0,0,09000064816d21b1
FDA-2011-N-0599-0002,FDA,FDA-2011-N-0599,"Report of Scientific and Medical Literature and Information on Non-Standardized Allergenic Extracts, etc.: Center for Biologics Evaluation and Research; Extension of Comment Period",Notice,Notice of Extension,2011-11-16T05:00:00Z,2011,11,2011-11-16T05:00:00Z,2012-04-26T03:59:59Z,2015-03-04T03:16:11Z,2011-29483,0,0,0900006480f6d690
FDA-2011-N-0599-0001,FDA,FDA-2011-N-0599,Report and Information on Non-Standardized Allergenic Extracts in Diagnosis and Treatment of Allergic Disease; Availability,Notice,Notice of Availability,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,2011-11-26T04:59:59Z,2012-04-27T12:02:13Z,2011-24598,0,0,0900006480f2bd4a